Thu, February 9, 2023
Wed, February 8, 2023
Tue, February 7, 2023

Chris Howerton Downgraded (URGN) to Hold and Decreased Target to $10 on, Feb 8th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-10-on-feb-8th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Chris Howerton of Jefferies, Downgraded "UroGen Pharma Ltd." (URGN) to Hold and Decreased Target from $35 to $10 on, Feb 8th, 2023.

Chris has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Chris's Rating of Hold.



This is the rating of the analyst that currently disagrees with Chris


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $23 on, Monday, December 12th, 2022

Publication Contributing Sources